Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15814967rdf:typepubmed:Citationlld:pubmed
pubmed-article:15814967lifeskim:mentionsumls-concept:C0040556lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0020861lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0205554lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C1510996lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0918012lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C0683597lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:15814967lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:15814967pubmed:issue4lld:pubmed
pubmed-article:15814967pubmed:dateCreated2005-4-7lld:pubmed
pubmed-article:15814967pubmed:abstractTextThe LIAISON system is a fully automated system based on chemiluminescence and antigen bound to magnetic microparticles. The system allows fast and precise measurement of Toxoplasma-specific immunoglobulin G (IgG) and IgM antibody levels and measurement of the IgG avidity index even at low levels of Toxoplasma-specific IgG antibodies in a single step without manual interference. Seven European centers participated in a multicenter evaluation of the LIAISON system. The sensitivity and specificity of the LIAISON system compared to the Sabin-Feldman dye test were 99.3 and 96.8%, respectively. In a comparison of the LIAISON Toxoplasma-specific IgM assay with an immunosorbent agglutination assay, the LIAISON assay had a sensitivity of 96.7% and a specificity of 95.4%. The LIAISON IgG assay showed agreements of 91, 100, and 100% with the AXSYM IgG (Abbott), VIDAS IgG (bioMerieux), and Platelia IgG (Bio-Rad) assays, respectively. The LIAISON IgM assay showed agreements of 95% with the AXSYM IgM and Platelia IgM assays, 96% with the ISAGA IgM assay (bioMerieux), and 97% with the VIDAS IgM assay. The coefficient of correlation between the LIAISON system and the VIDAS Toxoplasma-specific IgG avidity index was 0.81. By use of the Toxoplasma-specific IgG avidity index assay with specific IgM-positive samples, the diagnosis of infection with Toxoplasma gondii in early pregnancy has been improved significantly. The LIAISON avidity assay is a valuable assay for the exclusion of recently acquired infection with T. gondii (less than 4 months) in pregnant women, and it decreases significantly the necessity for follow-up testing.lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:languageenglld:pubmed
pubmed-article:15814967pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:citationSubsetIMlld:pubmed
pubmed-article:15814967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15814967pubmed:statusMEDLINElld:pubmed
pubmed-article:15814967pubmed:monthAprlld:pubmed
pubmed-article:15814967pubmed:issn0095-1137lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:ThulliezPhili...lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:NaessensAnneAlld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:LiesenfeldOli...lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:GuyEdwardElld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:PetersenEskil...lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:BorobioMaria...lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:MeroniValeria...lld:pubmed
pubmed-article:15814967pubmed:authorpubmed-author:SpranziEmmaElld:pubmed
pubmed-article:15814967pubmed:issnTypePrintlld:pubmed
pubmed-article:15814967pubmed:volume43lld:pubmed
pubmed-article:15814967pubmed:ownerNLMlld:pubmed
pubmed-article:15814967pubmed:authorsCompleteYlld:pubmed
pubmed-article:15814967pubmed:pagination1570-4lld:pubmed
pubmed-article:15814967pubmed:dateRevised2010-9-20lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:meshHeadingpubmed-meshheading:15814967...lld:pubmed
pubmed-article:15814967pubmed:year2005lld:pubmed
pubmed-article:15814967pubmed:articleTitleEuropean multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.lld:pubmed
pubmed-article:15814967pubmed:affiliationWHO/FAO International Centre for Research and Reference on Toxoplasmosis, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. eskildp@dadlnet.dklld:pubmed
pubmed-article:15814967pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15814967pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15814967pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:15814967pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15814967lld:pubmed